Quantitative Comparison of HSF1 Activators

被引:1
|
作者
Steurer, Christoph [1 ]
Kerschbaum, Sarah [1 ]
Wegrostek, Christina [1 ]
Gabriel, Stefan [1 ]
Hallaj, Ali [1 ]
Ortner, Viktoria [1 ]
Czerny, Thomas [1 ]
Riegel, Elisabeth [1 ]
机构
[1] Univ Appl Sci, Dept Appl Life Sci, FH Campus Wien,Helmut Qualtinger Gasse 2, A-1030 Vienna, Austria
关键词
Heat shock response; Neurodegenerative disease; HSF1; Luciferase assay; HEAT-SHOCK PROTEINS; TRANSCRIPTION FACTOR HSF1; ANTIINFLAMMATORY DRUGS; FACTOR-I; HYDROGEN-PEROXIDE; HUMAN-CELLS; CO-INDUCER; KAPPA-B; INDUCTION; STRESS;
D O I
10.1007/s12033-022-00467-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The heat shock response (HSR) pathway is a highly conserved rescue mechanism, which protects the cells from harmful insults disturbing the cellular protein homeostasis via expression of chaperones. Furthermore, it was demonstrated to play crucial roles in various diseases like neurodegeneration and cancer. For neurodegenerative diseases, an overexpression of chaperones is a potential therapeutic approach to clear the cells from non-functional protein aggregates. Therefore, activators of the HSR pathway and its master regulator HSF1 are under close observation. There are numerous HSR activators published in the literature using different model systems, experimental designs, and readout assays. The aim of this work was to provide a quantitative comparison of a broad range of published activators using a newly developed HSF responsive dual-luciferase cell line. Contrary to natural target genes, which are regulated by multiple input pathways, the artificial reporter exclusively reacts to HSF activity. In addition, the results were compared to endogenous heat shock protein expression. As a result, great differences in the intensity of pathway activation were observed. In addition, a parallel viability assessment revealed high variability in the specificity of the drugs. Furthermore, the differences seen compared to published data indicate that some activators exhibit tissue-specific differences leading to interesting assumptions about the regulation of HSF1.
引用
收藏
页码:873 / 887
页数:15
相关论文
共 50 条
  • [41] Reply to Christians: Hsf1 Knock-out
    Jones, W. Keith
    Tranter, Michael
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (48) : LE27 - LE27
  • [42] HSF1 Activation Can Restrict HIV Replication
    Nekongo, Emmanuel E.
    Ponomarenko, Anna, I
    Dewal, Mahender B.
    Butty, Vincent L.
    Browne, Edward P.
    Shoulders, Matthew D.
    ACS INFECTIOUS DISEASES, 2020, 6 (07): : 1659 - 1666
  • [43] Inhibiting the transcription factor HSF1 as an anticancer strategy
    Whitesell, Luke
    Lindquist, Susan
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (04) : 469 - 478
  • [44] HSF1的抗炎症作用机制
    王玉玺
    敖杰男
    中国医药导刊, 2009, 11 (01) : 99 - 100
  • [45] Rethinking HSF1 in Stress, Development, and Organismal Health
    Li, Jian
    Labbadia, Johnathan
    Morimoto, Richard I.
    TRENDS IN CELL BIOLOGY, 2017, 27 (12) : 895 - 905
  • [46] HSF1 and HSF3 cooperatively regulate the heat shock response in lizards
    Takii, Ryosuke
    Fujimoto, Mitsuaki
    Matsuura, Yuki
    Wu, Fangxu
    Oshibe, Namiko
    Takaki, Eiichi
    Katiyar, Arpit
    Akashi, Hiroshi
    Makino, Takashi
    Kawata, Masakado
    Nakai, Akira
    PLOS ONE, 2017, 12 (07):
  • [47] Expression of HSF1 and HSF2 by human odontoblasts exposed to LPS.
    Levin, LG
    Conrad, S
    Trope, M
    JOURNAL OF DENTAL RESEARCH, 1998, 77 : 799 - 799
  • [48] HSF1 induces TNFα gene in human cells independent of NFκB: Evidence for a pioneering pro-inflammatory signal by HSF1
    Ali, A.
    Pal, M.
    FEBS JOURNAL, 2017, 284 : 74 - 74
  • [49] HSF1Base: A Comprehensive Database of HSF1 (Heat Shock Factor 1) Target Genes
    Kovacs, Daniel
    Sigmond, Timea
    Hotzi, Bernadette
    Bohar, Balazs
    Fazekas, David
    Deak, Veronika
    Vellai, Tibor
    Barna, Janos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (22)
  • [50] Inhibition of Heat Shock Factor 1 (HSF1) Is More Effective At Sensitizing Myeloma Cells to Bortezomib Than Inhibition of Individual HSF1 Targets.
    Shah, Shardule P.
    Lonial, Sagar
    Boise, Lawrence H.
    BLOOD, 2012, 120 (21)